search
Company Information
USD
154.23
- (-0.05%)
NYSE:A, AGILENT TECHNOLOGIES, INC.
Industry: Diagnostics & Research
End of Day: 17 May 2024 GMT-4
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab (consisting of consumables and services related to life science and applied tools), and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. and China representing the largest country concentrations.

Address

5301 Stevens Creek Boulevard

Classification

Sector

Healthcare

Industry Group

Medical Diagnostics & Research

Industry

Diagnostics & Research

Key Executives

Mr. Michael R. McMullen
CEO/Director/President
Mr. Padraig McDonnell
COO
Mr. Dow R. Wilson
Director
Dr. George A. Scangos,PhD
Director
Dr. Otis W. Brawley,M.D.
Director
Dr. Daniel Podolsky, M.D.
Director
Mr. Boon Hwee Koh
Chairman of the Board/Director
Mr. Hans Edgar Bishop
Director
Ms. Heidi Kunz
Director
Dr. Mikael Dolsten, M.D.,PhD
Director
Ms. Susan H. Rataj
Director
Mr. Michael Tang
General Counsel/Secretary/Senior VP
Mr. Robert W. McMahon
CFO/Senior VP
Mr. Dominique Grau
Senior VP, Divisional
Mr. Rodney Gonsalves
Chief Accounting Officer/Controller/Vice President
Ms. Mala Anand
Director
Mr. Philip Binns
President, Divisional/Senior VP
Mr. Henrik Ancher-Jensen
President, Divisional/Senior VP

Ownership

Institution Holdings

BlackRock Inc
27,257,939 (9.301%)
Vanguard Group Inc
25,279,117 (8.626%)
Vanguard Group Inc. ( Junked)
25,277,234 (8.626%)
MFS Investment Management KK
13,246,489 (4.520%)
Massachusetts Financial Services Company
13,246,489 (4.520%)
T. Rowe Price
12,947,560 (4.418%)
State Street Corporation
12,634,456 (4.311%)
T. Rowe Price Investment Management,Inc.
10,154,406 (3.465%)
Wellington Management Company LLP
9,883,132 (3.372%)
BlackRock Fund Advisors
9,465,926 (3.230%)

Individual Holdings

Mr. Michael R. McMullen
306,206 (0.105%)
Mr. Robert W. McMahon
128,243 (0.044%)
Mr. Henrik Ancher-Jensen
82,504 (0.028%)
Mr. Dominique Grau
64,861 (0.022%)
Mr. Boon Hwee Koh
58,931 (0.020%)
Mr. Michael Tang
54,872 (0.019%)
Ms. Heidi Kunz
53,509 (0.017%)
Dr. Daniel Podolsky, M.D.
33,154 (0.011%)
Mr. Padraig McDonnell
27,317 (0.009%)
Mr. Rodney Gonsalves
26,133 (0.009%)

Funds Holdings

Vanguard Total Stock Market Index Fund
9,192,523 (3.137%)
Vanguard US Total Market Shares ETF
9,192,523 (3.137%)
Vanguard Institutional 500 Index Trust
7,229,395 (2.467%)
T. Rowe Price US Mid-Cap Growth Equity
4,966,300 (1.695%)
T. Rowe Price Mid-Cap Growth Fund
4,966,300 (1.695%)
Fidelity 500 Index Fund
3,438,264 (1.173%)
SPDR® S&P 500 ETF Trust
3,434,669 (1.172%)
iShares Core S&P 500 ETF
3,043,977 (1.039%)
Vanguard Growth Index Fund
2,691,246 (0.918%)
VanEck Morningstar Wide Moat ETF
2,647,036 (0.903%)

Details

Overview Company Info Key Ratios Income Balance Sheet Cash Flow
Make Smart Investment Choices